We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

102 hedge funds and large institutions have $321M invested in iShares US Pharmaceuticals ETF in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 32

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

8.04% less ownership

Funds ownership: 104.24% → 96.2% (-8%)

15% less funds holding

Funds holding: 120 → 102 (-18)

21% less capital invested

Capital invested by funds: $404M → $321M (-$83M)

74% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 23

Holders
102
Holders Change
-18
Holders Change %
-15%
% of All Funds
2.85%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
6
Increased
43
Reduced
32
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$5.8M
2
BWM
Braver Wealth Management
Massachusetts
+$4.94M
3
TRCT
Tower Research Capital (TRC)
New York
+$4.16M
4
RJFSA
Raymond James Financial Services Advisors
Florida
+$4.12M
5
Jane Street
Jane Street
New York
+$3.98M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$19.8M
2
RJA
Raymond James & Associates
Florida
-$8.4M
3
CCMG
Clark Capital Management Group
Pennsylvania
-$4.22M
4
UFF
USA Financial Formulas
Michigan
-$3.99M
5
LPL Financial
LPL Financial
California
-$3.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
OC
26
Oppenheimer & Co
New York
$2.78M +$294K +5,124 +10%
NPC
27
National Planning Corporation
California
$2.42M +$764K +13,323 +42%
Stifel Financial
28
Stifel Financial
Missouri
$2.16M +$76.7K +1,338 +3%
CAN
29
Cetera Advisor Networks
California
$2.12M +$437K +7,632 +22%
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$2.12M +$1.31M +22,881 +114%
ACM
31
Avalon Capital Management
California
$1.85M -$42.5K -741 -2%
EC
32
Estate Counselors
Wisconsin
$1.76M -$445K -7,770 -18%
PP
33
Patten & Patten
Tennessee
$1.7M -$132K -2,295 -6%
KCM
34
Karp Capital Management
California
$1.6M +$624K +10,890 +50%
CFA
35
Cahill Financial Advisors
Minnesota
$1.47M +$24.2K +423 +1%
CIBC World Market
36
CIBC World Market
Ontario, Canada
$1.38M -$1.09M -18,978 -40%
CPC
37
Cookson Peirce & Co
Pennsylvania
$1.32M -$123K -2,142 -7%
JP Morgan Chase
38
JP Morgan Chase
New York
$1.3M +$181K +3,150 +14%
SI
39
SII Investments
Wisconsin
$1.25M +$386K +6,738 +36%
SAM
40
Stringer Asset Management
Tennessee
$1.11M +$46.9K +819 +4%
VKH
41
Virtu KCG Holdings
New York
$1.11M +$891K +15,549 +226%
ICOA
42
Investment Centers of America
North Dakota
$1.09M +$2.75K +48 +0.2%
Koshinski Asset Management
43
Koshinski Asset Management
Illinois
$1.04M +$27.2K +474 +3%
PAMU
44
Pictet Asset Management (UK)
United Kingdom
$991K – – –
AMG
45
Asset Management Group
Connecticut
$953K -$70.5K -1,230 -6%
HH
46
Hilltop Holdings
Texas
$791K -$196K -3,411 -18%
Ameriprise
47
Ameriprise
Minnesota
$747K +$304K +5,310 +54%
US Bancorp
48
US Bancorp
Minnesota
$645K +$9.29K +162 +1%
Bank of New York Mellon
49
Bank of New York Mellon
New York
$630K +$733K +12,780 New
TYCC
50
Texas Yale Capital Corp
Florida
$551K – – –
1
2
3 4 5

IHE Hedge Fund Activity: Q3 2015 in Review

102 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2015, worth a combined $321M — down 21% from $404M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of IHE and 6 opened new positions — a net loss of 17 holders — while 32 trimmed existing stakes and 43 added.

The largest buyer was Susquehanna International Group, adding an estimated $5.8M. The largest seller was Morgan Stanley, cutting an estimated $19.8M.

  • 102 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2015, down from 120 in Q2 2015.
  • Funds reported $321M of iShares US Pharmaceuticals ETF stock for Q3 2015, down 21% quarter-over-quarter.
  • 6 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2015 and 23 closed out, a net change of -17 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2015 was Susquehanna International Group, an estimated $5.8M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2015 was Morgan Stanley, an estimated $19.8M sold.

Based on aggregated 13F filings for Q3 2015.